Events
‘Ask the author’ Session with Dr. Yasaman Vali from the Amsterdam University Medical Center, The Netherlands
This study reveals that while non-invasive liver tests (NITs) show comparable performance across patient subgroups, achieving consistent accuracy requires tailoring diagnostic thresholds to individual characteristics like diabetes status. Personalized diagnosis, rather than fixed thresholds, is crucial for accurate and timely management of MASLD, enhancing clinical care.
Ask the author session with Prof. Yasaman Vali available in video >‘Ask the author’ Session with Prof. Stefano Romeo from the University of Gothenburg, Sweden
Professor Romeo’s study identifies liver-specific and systemic MASLD phenotypes using data-driven cluster analysis. This differentiation allows for targeted treatments, addressing specific metabolic dysfunctions and improving patient outcomes .
Ask the author session with Prof. Stefano Romeo available in video >‘Ask the author’ Session with Prof. Maru Rinella from the University of Chicago, USA (in French)
Le Professeur Dufour et la Professeure Maru Rinella explorent l’utilisation du resmetirom pour traiter la stéatose hépatique non alcoolique, en détaillant les critères de sélection des patients, l’efficacité du médicament en combinaison avec des agonistes GLP-1, ainsi que les précautions à prendre concernant les effets secondaires et l’absence d’indication pour les patients cirrhotiques.
Ask the author session with Prof. Maru Rinella available in video >‘Ask the author’ Session with Prof. Mazen Noureddin from Houston Research Institute, USA
Professor Jean-François Dufour hosted Professor Mazen Noureddin to present his work on “Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis” published in the New England Journal of Medicine in June 2024.
Ask the author session with Prof. Mazen Noureddin available in video >‘Ask the author’ Session with Prof. Jérôme Boursier, in French
Professor Jean-François Dufour hosted Professor Jérôme Boursier to present his work on “SYNERGY-NASH” published in the New England Journal of Medicine on June 8, 2024.
Ask the author session with Prof. Jérôme Boursier available in video >‘Ask the author’ Session with Prof. Vincent Wong
Professor Jean-François Dufour hosted Professor Vincent Wong to present his work on “Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease,” published in JAMA in March 24.
Ask the author session with Prof. Vincent Wong available in video >HCC Day 2024
On the 29th of February 2024 was organized the HCC Day 2024 by the Swiss Foundation against Liver Cancer. The videos are available on demand on Klewel platform. Featuring A. Saborowski on How to select systemic therapy for HCC, R. Lencioni talking about TACE with I/O for HCC, K. Kelley on Combining chemotherapy and immunotherapy for first line biliary tract cancer, and more.
HCC Day 2024 lectures available on demand >International NASH Symposium – 2023 a pivotal year for NASH
On the 30th of November 2023 we organised the Swiss NASH Foundation Symposium – 2023 a pivotal year for NASH. If you missed it – or want to rewatch the talks – please enjoy the video on our YouTube Channel.
SwissNashFoundation YouTube >Speaker and Topics
Prof. Sven Francque, Belgium – Abandoning N for M, The new nomenclature
Dr. Naomi Lange, Switzerland – How to tackle MetALD
Manuel Romero-Gomez – Treating NASH with dual, triple agonists
Meena Bansal, MD – Targeting Thyroid Hormone Receptor in NASH
Prof. Jean-François Dufour, Switzerland – FGF21 agonists to treat NASH
Agenda
14:00 – 14:30
Prof. Francque – Abandoning N for M, The new nomenclature
14:30 – 15:00
Dr. Lange – How to tackle MetALD
15:00 – 15:30
Prof. Romero-Gomez – Treating NASH With Weight-Losing Drugs Dual Agonists
15:30 – 15:45
break
15:45 – 16:00
Carina Bobzin – Vorstellung Swiss HePa
16:00 – 16:30
The Max Meyer Prize: Award Ceremony
16:30 – 17:00
M. Bansal – Targeting Thyroid Hormone Receptor in NASH
17:00 – 17:30
Prof. Dufour – FGF21 agonists to treat NASH
Online Registration
Registration is closed.
Sponsors
A very big thanks to our sponsors!
Madrigal Pharmaceuticals
